Cellectar Biosciences Azioni (NASDAQ: CLRB)

Cellectar Biosciences (NASDAQ:CLRB) Azioni, Quote.MetaTitle.unusual-options

Cellectar Biosciences

Cellectar Biosciences, Inc. - Common Stock

Panoramica

Notizie

Utili

Opzioni

Valutazioni degli analisti

Insider trading

Vendite allo scoperto

Rapporto azionario

Cellectar Biosciences Inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of drugs for the treatment of cancer. The company's core objective is to leverage a proprietary phospholipid drug conjugate (PDC) delivery platform to develop PDCs that are designed to specifically target cancer cells and deliver improved efficacy and safety as a result of fewer off-target effects. It has one operating and reportable segment focused on utilizing its PDC platform to develop drugs for the treatment of cancer.

Comments

Cellectar Biosciences Opzioni Inusuali

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO